EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›LOAN

LOAN

MANHATTAN BRIDGE CAPITAL, INC

Next earnings Jul 17, 2026 · consensus $0.11 EPS, $1.38M rev

Hold
$4.45
▲ 0.00%
$4.45▼ -6.86%
over 1Y
L $4.14EODHDH $5.32
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W+0.7%
1M+5.2%
3M+2.3%
YTD-1.6%
1Y-6.9%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B-
Valuation
Fair value
Filings
Flagged
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 6 analysts
Sell

Strong net margin (59.0%); but revenue fell -10.6% YoY.

Revenue (FY2025) $8.67M · FY2025

The read

Fundamentals and price both look middling — no strong edge either way.

MANHATTAN BRIDGE CAPITAL, INC shows $8.67M in FY2025 revenue (-10.6% YoY), a 59.0% net margin, and 11.9% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$6.81M$8.57M$9.80M$9.69M$8.67M
Gross profit—————
Operating income$4.41M$5.19M$5.44M$5.57M$5.09M
Net income$4.42M$5.21M$5.48M$5.59M$5.11M
Diluted EPS$0.42$0.45$0.48$0.49$0.45
Net margin65.0%60.8%55.9%57.7%59.0%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$57.0M
EV / EBITDA—
EV / Sales6.6
EV / FCF11.6
P / FCF10.3
PEG (trailing)—
Earnings yield10.0%
FCF yield9.7%

Quality & risk

ROIC (est.)8.2%
Free cash flow$4.93M
Total debt$6.25M
Net cash-$6.11M
Altman Z-Score2.35 grey
Piotroski F-Score4/7

Capital returns

Buyback yield—
Dividend yield (est.)10.3%
Shareholder yield10.3%
Shares Δ YoY-0.1%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — agreement terminated (2025-12-16). Worth a closer look.
  1. 8-K Shareholder vote2026-06-18
  2. DEF 14A Proxy statement2026-05-08
  3. 10-Q Quarterly report2026-04-16
  4. 10-K Annual report2026-03-27
  5. 8-K Material agreement2026-02-25
  6. 8-K Agreement terminated2025-12-16
  7. 8-K Other event2025-11-26
  8. 8-K Other event2025-11-20
  9. 10-Q Quarterly report2025-10-24

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-182026-06-18open ↗ARSPeriod ending 2025-12-312026-05-08open ↗DEFA14AFiling2026-05-08open ↗DEF 14APeriod ending 2026-05-082026-05-08open ↗10-QPeriod ending 2026-03-312026-04-16open ↗10-KPeriod ending 2025-12-312026-03-27open ↗8-KPeriod ending 2026-02-242026-02-25open ↗8-KPeriod ending 2025-12-122025-12-16open ↗8-KPeriod ending 2025-11-262025-11-26open ↗8-KPeriod ending 2025-11-202025-11-20open ↗4Period ending 2025-11-192025-11-19open ↗4Period ending 2025-11-172025-11-18open ↗

Quality score

B-
ValueGrowthProfitHealthMom.
ValueB+
GrowthF
ProfitabilityA
Financial healthA-
Momentum—
  • ✗Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✓P/E below 25

Fair value est.

$4.02

Fairly valued -10% vs price

cheapfair valueexpensive

Modified Graham: EPS $0.45 × (8.5 + 1.5 × 0.0% growth) × 1.05 quality = 8.9× multiple. An estimate, not a price target.

Revenue
$8.67M
-10.6% YoY
Net margin
59.0%
ROE
11.9%
P/E
9.9

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$8.67M-10.6%
Net income$5.11M-8.6%
Operating income$5.09M-8.6%
Diluted EPS$0.45-8.2%
Cash & equivalents$136K+41.7%
Total assets$62.4M-7.4%
Total liabilities$19.3M-20.1%
Stockholders' equity$43.1M-0.4%
Op.: 58.8%L/E: 0.45x

Frequently asked

Is MANHATTAN BRIDGE CAPITAL, INC (LOAN) a buy?
LOAN currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Strong net margin (59.0%); but revenue fell -10.6% YoY.
What is LOAN's fair value?
A Modified-Graham model based on LOAN's SEC fundamentals estimates a fair value of about $4.02. It is an estimate from reported earnings, not a price target.
Is LOAN overvalued or undervalued?
Against a Modified-Graham fair-value estimate, LOAN currently appears fairly valued relative to its SEC-grounded earnings power.
What is MANHATTAN BRIDGE CAPITAL, INC's quality score?
LOAN scores 68.33333333333331/100 (grade B-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001080340, latest 10-Q filed 2026-04-16) · EODHD · as of 6/22/2026, 9:51:51 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2025-11-19
Bentovim Lyron L
Director
Buy1.76K @ $4.52$7.94K
2025-11-17
RAN ASSAF
President and CEO
Buy4.00K @ $4.65$18.6K
2023-05-12
RAN ASSAF
President and CEO
Buy5.00K @ $4.94$24.7K
2023-04-26
RAN ASSAF
President and CEO
Buy319.00 @ $5.05$1.61K
2023-04-25
RAN ASSAF
President and CEO
Buy1.72K @ $5.00$8.61K
2023-04-25
RAN ASSAF
President and CEO
Buy960.00 @ $4.97$4.77K
2023-04-24
RAN ASSAF
President and CEO
Buy5.00K @ $5.01$25.1K
2022-10-21
RAN ASSAF
President and CEO
Buy8.00K @ $5.42$43.3K
2022-06-17
JACKSON MICHAEL
Director
Buy1.00K @ $5.35$5.35K
2022-06-16
JACKSON MICHAEL
Director
Buy1.34K @ $5.35$7.19K
2022-05-23
JACKSON MICHAEL
Director
Buy2.00K @ $5.40$10.8K

Dividends

Quarterly
Yield (TTM)
12.7%
Annual / share
$0.57
Last ex-date
2026-07-08
Last amount
$0.11
ex 2026-07-08paid 2026-07-15$0.11
ex 2026-04-08paid 2026-04-15$0.11
ex 2025-12-31paid 2026-01-15$0.12
ex 2025-10-08paid 2025-10-15$0.12
ex 2025-07-08paid 2025-07-15$0.12
ex 2025-04-08paid 2025-04-15$0.12

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Recent news

market news →
Upcoming Dividend Run For LOAN?Bullish
nasdaq.com· 2026-06-23
Manhattan Bridge Capital declares $0.11 dividendBullish
seekingalpha.com· 2026-03-31
Manhattan Bridge Capital, Inc. Reports 2025 ResultsBullish
globenewswire.com· 2026-03-27
Manhattan Bridge Capital, Inc. Declares Quarterly DividendBullish
globenewswire.com· 2026-02-10
Stock Market Today, Jan. 9: Rocket Companies Surges After Trump Floats $200 Billion Mortgage Bond Purchase PlanBullish
finance.yahoo.com· 2026-01-09
Stock Market Today, Jan. 9: Rocket Companies Surges After Trump Floats $200 Billion Mortgage Bond Purchase PlanBullish
nasdaq.com· 2026-01-09

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score68 vs 67
Revenue growth-10.6% vs 7.1%
Net margin59.0% vs 10.5%
Return on equity11.9% vs 12.3%
P/E9.9 vs 25.5